Depersonalization–derealization disorder: a contemporary review of definitions, neurobiology, and treatment approaches.
DOI:
https://doi.org/10.12775/JEHS.2025.86.67440Keywords
depersonalization, derealization, DPDR, dissociative disorders, cognitive behavioral therapyAbstract
Background
Depersonalization/derealization disorder (DPDR) is a rare mental disorder in which patients experience a sense of detachment from themselves or their surroundings. Despite clearly defined diagnostic criteria, this disorder is often unrecognized or confused with other mental illnesses, such as depression or anxiety disorders.
Aim
This article aims to review the current knowledge on the definition, epidemiology, clinical knowledge, neurobiology, and treatment options for DPDR.
Materials and Methods
A narrative review of the literature available in PubMed, Google Scholar, and Web of Science databases was conducted. The analysis covered works published up to December 2025.
Results
DPDR affects approximately 1% of the general population and often co-occurs with other mental disorders. Symptoms may be episodic or chronic and significantly affect patients' quality of life. Cognitive-behavioral therapy remains the best-documented treatment, while the effectiveness of pharmacotherapy and neuromodulation remains unclear due to limited studies.
Conclusions
DPDR is a distinct and clinically significant disorder that warrants greater diagnostic and therapeutic attention. Further research, extensive controlled clinical trials, is needed to develop more effective treatment strategies.
References
1. Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol. 2004 Jan;39(1):9-18. doi: 10.1007/s00127-004-0701-4. PMID: 15022041.
2. Diagnostic and Statistical Manual of Mental Disorders, 5th edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing, Washington, DC, p 329.
3. Yang J, Millman LSM, David AS, Hunter ECM. The Prevalence of Depersonalization-Derealization Disorder: A Systematic Review. J Trauma Dissociation. 2023 Jan-Feb;24(1):8-41. doi: 10.1080/15299732.2022.2079796. Epub 2022 Jun 14. PMID: 35699456.
4. Simeon D, Guralnik O, Schmeidler J, Sirof B, Knutelska M. The role of childhood interpersonal trauma in depersonalization disorder. Am J Psychiatry. 2001 Jul;158(7):1027-33. doi: 10.1176/appi.ajp.158.7.1027. PMID: 11431223.
5. Sierra M, David AS. Depersonalization: a selective impairment of self-awareness. Conscious Cogn. 2011 Mar;20(1):99-108. doi: 10.1016/j.concog.2010.10.018. Epub 2010 Nov 17. PMID: 21087873.
6. Simeon, Daphne & Abugel, Jeffrey. (2006). Feeling Unreal: Depersonalization Disorder and the Loss of Self. 10.1093/oso/9780195170221.001.0001.
7. Medford, Nick. (2012). Emotion and the Unreal Self: Depersonalization Disorder and De-Affectualization. Emotion Review. 4. 139-144. 10.1177/1754073911430135.
8. Lambert MV, Senior C, Phillips ML, Sierra M, Hunter E, David AS. Visual imagery and depersonalisation. Psychopathology. 2001 Sep-Oct;34(5):259-64. doi: 10.1159/000049319. PMID: 11799321.
9. Mathilde Horn, Thomas Fovet, Guillaume Vaiva, Pierre Thomas, Ali Amad, Fabien D’Hondt, Emotional response in depersonalization: A systematic review of electrodermal activity studies, Journal of Affective Disorders, Volume 276, 2020, Pages 877-882, ISSN 0165-0327, https://doi.org/10.1016/j.jad.2020.07.064. (https://www.sciencedirect.com/science/article/pii/S016503272032509X)
10. Simeon D. Depersonalisation disorder: a contemporary overview. CNS Drugs. 2004;18(6):343-54. doi: 10.2165/00023210-200418060-00002. PMID: 15089102.
11. Michal M, Wiltink J, Tibubos AN, Wild PS, Münzel T, Lackner K, Pfeiffer N, König J, Gieswinkel A, Beutel M, Kerahrodi JG. Impact of depersonalization on the course of depression: longitudinal observations from the gutenberg health study. BMC Psychiatry. 2024 Mar 8;24(1):196. doi: 10.1186/s12888-024-05658-7. PMID: 38459472; PMCID: PMC10924423.
12. Diagnostic and statistical manual of mental disorders : DSM-5 (5th ed.). Arlington, VA: American Psychiatric Association. 2013. pp. 302–306. ISBN 9780890425541.
13. https://icd.who.int/browse/2025-01/mms/en#253124068
14. Mauricio Sierra, German E. Berrios, The Cambridge Depersonalisation Scale: a new instrument for the measurement of depersonalisation, Psychiatry Research, Volume 93, Issue 2, 2000, Pages 153-164, ISSN 0165-1781, https://doi.org/10.1016/S0165-1781(00)00100-1. (https://www.sciencedirect.com/science/article/pii/S0165178100001001)
15. Hunter EC, Phillips ML, Chalder T, Sierra M, David AS. Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behav Res Ther. 2003 Dec;41(12):1451-67. doi: 10.1016/s0005-7967(03)00066-4. PMID: 14583413.
16. Wilkhoo HS, Islam AW, Reji F, Sanghvi L, Potdar R, Solanki S. Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management. Discoveries (Craiova). 2024 Jun 30;12(2):e190. doi: 10.15190/d.2024.09. PMID: 40093848; PMCID: PMC11910194.
17. Sierra M, David AS. Depersonalization: a selective impairment of self-awareness. Conscious Cogn. 2011 Mar;20(1):99-108. doi: 10.1016/j.concog.2010.10.018. Epub 2010 Nov 17. PMID: 21087873.
18. Saini, F., Ponzo, S., Silvestrin, F. et al. Depersonalization disorder as a systematic downregulation of interoceptive signals. Sci Rep 12, 22123 (2022). https://doi.org/10.1038/s41598-022-22277-y
19. Hunter ECM, Ring L, Gafoor R, Morant N, Lewis G, Perkins J, Dalrymple N, Dumitru A, Wong CLM, Pizzo E, McRedmond G, David AS. Cognitive Behavior Therapy for Depersonalization-Derealization Disorder (CBT-f-DDD): a feasibility randomized trial. Pilot Feasibility Stud. 2025 Dec 10. doi: 10.1186/s40814-025-01742-1. Epub ahead of print. PMID: 41373023.
20. Simeon D, Knutelska M. An open trial of naltrexone in the treatment of depersonalization disorder. J Clin Psychopharmacol. 2005 Jun;25(3):267-70. doi: 10.1097/01.jcp.0000162803.61700.4f. PMID: 15876908.
21. Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J Psychopharmacol. 2003 Mar;17(1):103-5. doi: 10.1177/0269881103017001712. PMID: 12680746.
22. Sierra M, Baker D, Medford N, Lawrence E, Patel M, Phillips ML, David AS. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases. Clin Neuropharmacol. 2006 Sep-Oct;29(5):253-8. doi: 10.1097/01.WNF.0000228368.17970.DA. PMID: 16960469.
23. Wang S, Zheng S, Zhang X, Ma R, Feng S, Song M, Zhu H, Jia H. The Treatment of Depersonalization-Derealization Disorder: A Systematic Review. J Trauma Dissociation. 2024 Jan-Feb;25(1):6-29. doi: 10.1080/15299732.2023.2231920. Epub 2023 Jul 11. PMID: 37431255.
24. Karris BC, Capobianco M, Wei X, Ross L. Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation. J Psychiatr Pract. 2017 Mar;23(2):141-144. doi: 10.1097/PRA.0000000000000215. PMID: 28291040.
25. Wilkhoo HS, Islam AW, Reji F, Sanghvi L, Potdar R, Solanki S. Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management. Discoveries (Craiova). 2024 Jun 30;12(2):e190. doi: 10.15190/d.2024.09. PMID: 40093848; PMCID: PMC11910194.
26. Millman LSM, Hunter ECM, Orgs G, David AS, Terhune DB. Symptom variability in depersonalization-derealization disorder: A latent profile analysis. J Clin Psychol. 2022 Apr;78(4):637-655. doi: 10.1002/jclp.23241. Epub 2021 Sep 6. PMID: 34487354.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marta Czechowicz, Joanna Madoń, Patryk Gadziński

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 7
Number of citations: 0